Glioblastoma‐associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties
暂无分享,去创建一个
Philippe Menei | Anne Clavreul | L. Lemaire | A. Clavreul | O. Coqueret | P. Menei | C. Guette | Audrey Rousseau | Olivier Coqueret | Alice Boissard | Cécile Henry | Tony Avril | Laurent Lemaire | A. Rousseau | Catherine Guette | Rogatien Faguer | Clément Tétaud | Alice Boissard | Cécile Henry | T. Avril | R. Faguer | C. Tétaud
[1] K. Camphausen,et al. Orthotopic growth of human glioma cells quantitatively and qualitatively influences radiation-induced changes in gene expression. , 2005, Cancer research.
[2] D. Berney,et al. Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib , 2011, Oncogene.
[3] L. Ellis,et al. 19.3 n&v MH IF , 2009 .
[4] Hui Wang,et al. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis. , 2010, Cancer research.
[5] Kevin Petrecca,et al. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma , 2012, Journal of Neuro-Oncology.
[6] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[7] Q. Ding,et al. Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma , 2012, Oncology letters.
[8] A. Omuro. Exploring multi-targeting strategies for the treatment of gliomas. , 2008, Current opinion in investigational drugs.
[9] E. Gamelin,et al. Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation , 2008, Proteome Science.
[10] Tom T. Chen,et al. ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1 , 2012, Nature Medicine.
[11] Xiandong Lin,et al. Overexpression of thrombospondin‐1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma , 2012, Journal of surgical oncology.
[12] B. Rosen,et al. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation , 2013, Proceedings of the National Academy of Sciences.
[13] I. Christensen,et al. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. , 1983, Cytometry.
[14] T. Taxt,et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma , 2011, Proceedings of the National Academy of Sciences.
[15] C. James,et al. Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion , 2012, Molecular Cancer.
[16] P. Schiller,et al. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. , 2010, Biomaterials.
[17] J. A. van der Laak,et al. Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2 , 2013, PloS one.
[18] M. Grigorian,et al. Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion. , 2012, Neoplasia.
[19] J. Dedman,et al. Annexins II and V inhibit cell migration. , 1997, Experimental cell research.
[20] E. Wawrousek,et al. alphaB-crystallin regulation of angiogenesis by modulation of VEGF. , 2010, Blood.
[21] H. Dvorak,et al. Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer. , 2012, Cancer research.
[22] J. Kros,et al. A crucial role of caldesmon in vascular development in vivo. , 2008, Cardiovascular research.
[23] R. Barnard,et al. The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.
[24] Tracy T Batchelor,et al. Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. , 2011, Cancer research.
[25] Michal Neeman,et al. In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. , 2007, Cancer research.
[26] H. Koyama,et al. Loss of smooth muscle calponin results in impaired blood vessel maturation in the tumor–host microenvironment , 2007, Cancer science.
[27] A. Aboussekhra,et al. Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic , 2013, The Journal of pathology.
[28] G. Bergers,et al. Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma. , 2013, CNS oncology.
[29] Shalom Madar,et al. 'Cancer associated fibroblasts'--more than meets the eye. , 2013, Trends in molecular medicine.
[30] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[31] D. Cheresh,et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. , 2012, Cancer cell.
[32] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[33] P. Malfertheiner,et al. Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density , 2001, Virchows Archiv.
[34] Thomas D. Pollard,et al. Actin, a Central Player in Cell Shape and Movement , 2009, Science.
[35] G. Maira,et al. The influence of surgery on recurrence pattern of glioblastoma , 2013, Clinical Neurology and Neurosurgery.
[36] A. Orimo,et al. Carcinoma‐associated fibroblasts: Non‐neoplastic tumour‐promoting mesenchymal cells , 2013, Journal of cellular physiology.
[37] J. McCarty. Glioblastoma Resistance to Anti-VEGF Therapy: Has the Challenge Been MET? , 2013, Clinical Cancer Research.
[38] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[39] S. Takano. Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation , 2012, Brain Tumor Pathology.
[40] J. Bruna,et al. Bevacizumab for the Treatment of Glioblastoma , 2013, Clinical Medicine Insights. Oncology.
[41] V. Shah,et al. Focal adhesion assembly in myofibroblasts fosters a microenvironment that promotes tumor growth. , 2010, The American journal of pathology.
[42] John N. Weinstein,et al. High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID) , 2005, BMC Bioinformatics.
[43] N. Erez,et al. From sentinel cells to inflammatory culprits: cancer‐associated fibroblasts in tumour‐related inflammation , 2013, The Journal of pathology.
[44] Herbert J Zeh,et al. High-mobility group box 1 and cancer. , 2010, Biochimica et biophysica acta.
[45] T. Tokuyasu,et al. Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance , 2013, Clinical Cancer Research.
[46] Scott D. Hansen,et al. In vitro studies of actin filament and network dynamics. , 2013, Current opinion in cell biology.
[47] P. A. Futreal,et al. Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma. , 2010, Cancer research.
[48] W A Buurman,et al. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1 , 2013, Oncogene.
[49] H. Immervoll,et al. Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma , 2011, PloS one.
[50] L. Claesson‐Welsh,et al. alphaB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. , 2008, Blood.
[51] J. Mosser,et al. Isolation of a new cell population in the glioblastoma microenvironment , 2012, Journal of Neuro-Oncology.
[52] W. Jiang,et al. αB-Crystallin, an Effector of Unfolded Protein Response, Confers Anti-VEGF Resistance to Breast Cancer via Maintenance of Intracrine VEGF in Endothelial Cells , 2011, Molecular Cancer Research.
[53] B. Geiger,et al. Environmental sensing through focal adhesions , 2009, Nature Reviews Molecular Cell Biology.